Form 4 Filing for Dexcom Inc. - Officer Stock Transaction

Jereme M. Sylvain, EVP, Chief Financial Officer of Dexcom Inc. (DXCM), reported a disposition of 1,451 shares of common stock on May 22, 2026. The transaction, executed at a price of $71.90 per share, resulted in a post-transaction holding of 151,841 shares. Footnote F1 clarifies that the disposed shares were withheld by the Issuer to cover tax obligations related to the net settlement of restricted stock units. Footnote F2 provides details on the composition of the post-transaction shares, including various unvested restricted stock units granted between March 2024 and March 2026, with vesting schedules extending through March 2029.